my mhealth and collaborators awarded €2.5m Eurostars Grant for better heart health project

Immersive cardiac rehabilitation app, myHeart, uses behavioural feedback and gamification features to improve patient wellbeing

Am international collaboration led my digital therapeutics company, my mhealth, has been awarded a €2.5m Eurostars Grant for the development of an innovative cardiac rehabilitation app.

Eurostars is a European joint programme co-funded from the national budgets of 36 EUREKA countries and by the European Union through Horizon 2020.

As a UK funding body, Innovate UK will sponsor my mhealth to develop part of its myHeart app to support cardiac rehabilitation in Europe.

Together with three accomplished European partners; Ospedale Malcantonese (OSCAM) from Switzerland; Games for Health from the Netherlands; and the University of Applied Sciences and Arts of Southern Switzerland (SUPSI); the project aims to utilise the cardiac rehabilitation element of the myHeart app and incorporate biofeedback, intelligent algorithms, and gamification features.

Each organisation brings a very-unique perspective to the table, allowing for a thoughtful and comprehensive approach to tackling heart health

During the three years of planning and development, the platform will be researched in the UK and several European countries through formal clinical trials.

Known as the CUOREMA project, it will focus on developing a new, patient-centred and intelligent cardiac rehabilitation support system.

The scalable, customisable, and flexible technology will provide a new systematic method of social and biological feedback from wearable devices, and the app will include built-in behaviour change support systems, with mixed reality and immersive technology to improve medical adherence and clinical outcomes.

As the project lead, my mhealth is clinical and technological experts in digital healthcare applications for long-term conditions, with COPD as a primary area of focus.

Its expertise in this arena, and vision and experience in digital therapeutics, was recognised by the judging panel.

In particular, the project achieved the highest scores in the Innovation & R&D category.

Following strict guidelines, the app will be compatible for use across the European Union, and, once developed, the content will be available in five languages: French, Italian, Portuguese, German and Spanish.

I am extremely passionate about digital health and this has the potential to change many lives for the better, helping us transform cardiac rehabilitation for patients across Europe

Dr Simon Bourne, chief executive of my mhealth, said: “We are thrilled to be partnering with such talented and diverse teams on this innovative and important project over the next few years.

“Each organisation brings a very-unique perspective to the table, allowing for a thoughtful and comprehensive approach to tackling heart health.

“I am extremely passionate about digital health and this has the potential to change many lives for the better, helping us transform cardiac rehabilitation for patients across Europe.”

Companies